Abstract
s / Brain Stimulation 8 (2015) 395e411 396 included age, gender, years with disease, doses of L-DOPA, dyskinesias, stadium by Hoehn and Yahr. rTMS was performed with a Magstim Rapid2, 5 consecutive days, for 3 months, resting 3 weeks per month, 100 pulses, 25 Hz, 80% of motor threshold. Results: We recruited a total of 2 men and 2 women, stadium Hoehn and Yahr 1.5-3, age 67 8. 76, 7.75 2. 5 years with PD, basal doses of L-dopa 850 270.80 with dyskinesias type 3 in 3 patients and basal UPDR of 53 26.99. After the third week of rTMS, patients were able to score by UPDRS 40.75 20.23, and revealed a dose reduction in L-DOPA of 578.12 93.74. Conclusions: According with the clinical features of our patients, the predominant type of dyskinesias is type 3. Preliminary results in response to rTMS treatment showa reduction in the UPDRS scale, as well as a decrease in L-DOPA dosage, which could be reduced monthly in all 4 patients.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
